Literature DB >> 21105798

The role of allogeneic-cell transplantation in leukemia.

John H Kersey.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 21105798     DOI： 10.1056/NEJMe1010818

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy.

Authors:  Abraham J Wilhelm; Peer de Graaf; Agnes I Veldkamp; Jeroen J W M Janssen; Peter C Huijgens; Eleonora L Swart
Journal:  Br J Clin Pharmacol       Date:  2012-04       Impact factor: 4.335

Review 2.  Stem cell transplantation for indolent lymphoma: a reappraisal.

Authors:  Koen van Besien
Journal:  Blood Rev       Date:  2011-09       Impact factor: 8.250

3.  Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies.

Authors:  Mohamed L Sorror; Brenda M Sandmaier; Barry E Storer; Georg N Franke; Ginna G Laport; Thomas R Chauncey; Edward Agura; Richard T Maziarz; Amelia Langston; Parameswaran Hari; Michael A Pulsipher; Wolfgang Bethge; Firoozeh Sahebi; Benedetto Bruno; Michael B Maris; Andrew Yeager; Finn Bo Petersen; Lars Vindeløv; Peter A McSweeney; Kai Hübel; Marco Mielcarek; George E Georges; Dietger Niederwieser; Karl G Blume; David G Maloney; Rainer Storb
Journal:  JAMA       Date:  2011-11-02       Impact factor: 56.272

4.  HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia: Results From the Microtransplantation Interest Group.

Authors:  Mei Guo; Nelson J Chao; Jian-Yong Li; David A Rizzieri; Qi-Yun Sun; Ann Mohrbacher; Elizabeth F Krakow; Wan-Jun Sun; Xu-Liang Shen; Xin-Rong Zhan; De-Pei Wu; Li Liu; Juan Wang; Min Zhou; Lin-Hua Yang; Yang-Yi Bao; Zheng Dong; Bo Cai; Kai-Xun Hu; Chang-Lin Yu; Jian-Hui Qiao; Hong-Li Zuo; Ya-Jing Huang; Anthony D Sung; Jun-Xiao Qiao; Zhi-Qing Liu; Tie-Qiang Liu; Bo Yao; Hong-Xia Zhao; Si-Xuan Qian; Wei-Wei Liu; Rafael Forés; Rafael F Duarte; Hui-Sheng Ai
Journal:  JAMA Oncol       Date:  2018-01-01       Impact factor: 31.777

5.  The pretransplant systemic metabolic profile reflects a risk of acute graft versus host disease after allogeneic stem cell transplantation.

Authors:  Håkon Reikvam; Kimberley Hatfield; Øystein Bruserud
Journal:  Metabolomics       Date:  2015-11-16       Impact factor: 4.290

6.  Low-dose decitabine priming with intermediate-dose cytarabine followed by umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia: a phase II single-arm study.

Authors:  Xiaoyang Li; Yuexin Dong; Ya Li; Ruibao Ren; Wen Wu; Hongming Zhu; Yunxiang Zhang; Jiong Hu; Junmin Li
Journal:  BMC Cancer       Date:  2019-08-20       Impact factor: 4.430

7.  Third-party type 2 innate lymphoid cells prevent and treat GI tract GvHD.

Authors:  Danny W Bruce; Oleg Kolupaev; Sonia J Laurie; Hemamalini Bommiasamy; Heather Stefanski; Bruce R Blazar; James M Coghill; Jonathan S Serody
Journal:  Blood Adv       Date:  2021-11-23

Review 8.  Stem Cell Therapy and Innate Lymphoid Cells.

Authors:  Divya Verma; Mukesh Verma; Rangnath Mishra
Journal:  Stem Cells Int       Date:  2022-08-02       Impact factor: 5.131

9.  Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease.

Authors:  Danny W Bruce; Heather E Stefanski; Benjamin G Vincent; Trisha A Dant; Shannon Reisdorf; Hemamalini Bommiasamy; David A Serody; Justin E Wilson; Karen P McKinnon; Warren D Shlomchik; Paul M Armistead; Jenny P Y Ting; John T Woosley; Bruce R Blazar; Dietmar M W Zaiss; Andrew N J McKenzie; James M Coghill; Jonathan S Serody
Journal:  J Clin Invest       Date:  2017-04-04       Impact factor: 14.808

10.  Donor γδT Cells Promote GVL Effect and Mitigate aGVHD in Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Yuan Song; Ying Zhu; Bo Hu; Yonghao Liu; Dandan Lin; Ziqi Jin; Zhinan Yin; Chen Dong; Depei Wu; Haiyan Liu
Journal:  Front Immunol       Date:  2020-10-16       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.